Journal of Zhejiang University SCIENCE B

, Volume 10, Issue 7, pp 493–498 | Cite as

Advances in researches on the immune dysregulation and therapy of severe acute pancreatitis

Review

Abstract

During the development and progression of severe acute pancreatitis (SAP), conspicuous immune dysregulation develops, which is mainly manifested as excessive immune response in the early stage and immunosuppression in the late stage. This process involves complex changes in a variety of immune molecules and cells, such as cytokines, complements, lymphocytes, and leukocytes. With the gradual deepening of studies on the development and progression of SAP, the role of immune dysregulation in the pathogenesis of SAP has attracted more and more attention. In this article, we review the advances in research on the immune dysregulation in SAP and the immunotherapy of this disease through exploring the formation of excessive immune response and immune suppression as well as their mutual transformation.

Key words

Severe acute pancreatitis (SAP) Immune Dysregulation Treatment 

CLC number

R58 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Al Mofleh, I.A., 2008. Severe acute pancreatitis: pathogenetic aspects and prognostic factors. World J. Gastroenterol., 14(5):675–684. [doi:10.3748/wjg.14.675]PubMedCrossRefGoogle Scholar
  2. Armutcu, F., Coskun, O., Gürel, A., Kanter, M., Can, M., Ucar, F., Unalacak, M., 2005. Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats. Clin. Biochem., 38(6):540–547. [doi:10.1016/j.clinbiochem.2005.01.013]PubMedCrossRefGoogle Scholar
  3. Ayala, A., Chung, C.S., Song, G.Y., Chaudry, I.H., 2001. IL-10 mediation of activation-induced TH1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis. Cytokine, 14(1):37–48. [doi:10.1006/cyto.2001.0848]PubMedCrossRefGoogle Scholar
  4. Beger, H.G., Rau, B.M., 2007. Severe acute pancreatitis: clinical course and management. World J. Gastroenterol., 13(38):5043–5051.PubMedGoogle Scholar
  5. Chen, C., Xia, S.H., Chen, H., Li, X.H., 2008. Therapy for acute pancreatitis with platelet-activating factor receptor antagonists. World J. Gastroenterol., 14(30):4735–4738. [doi:10.3748/wjg.14.4735]PubMedCrossRefGoogle Scholar
  6. Chen, X.L., Huang, X.L., Wu, H., 2002. Modulation of disorder of inflammatory-associated cytokines with immunosuppressive agents in acute pancreatitis. Chinese Journal of Bases and Clinics in General Surgery, 9(6):384–387 (in Chinese).Google Scholar
  7. DiMagno, M.J., DiMagno, E.P., 2007. New advances in acute pancreatitis. Curr. Opin. Gastroenterol., 23(5):494–501.PubMedGoogle Scholar
  8. Fink, M.P., 2008. Ethyl pyruvate. Curr. Opin. Anaesthesiol., 21(2):160–167. [doi:10.1097/ACO.0b013e3282f63c2e]PubMedCrossRefGoogle Scholar
  9. Frossard, J.L., Steer, M.L., Pastor, C.M., 2008. Acute pancreatitis. Lancet, 371(9607):143–152. [doi:10.1016/S0140-6736(08)60107-5]PubMedCrossRefGoogle Scholar
  10. Fushimi, T., Okayama, H., Seki, T., Shimura, S., Shirato, K., 1997. Dexamethasone suppressed gene expression and production of interleukin-10 by human peripheral blood mononuclear cells and monocytes. Int. Arch. Allergy Immunol., 112(1):13–18.PubMedCrossRefGoogle Scholar
  11. Gloor, B., Stahel, P.F., Müller, C.A., Schmidt, O.I., Büchler, M.W., Uhl, W., 2003. Predictive value of complement activation fragments C3a and sC5b-9 for development of severe disease in patients with acute pancreatitis. Scand. J. Gastroenterol., 38(10):1078–1082. [doi:10.1080/00365520310005965]PubMedCrossRefGoogle Scholar
  12. Han, X.C., Zhang, Y.C., Wang, Y., Jia, M.K., 2003. Clinical evaluation of serum interleukin 10 in patients with acute pancreatitis. Hepatobiliary Pancreat. Dis. Int., 2(1): 135–138.PubMedGoogle Scholar
  13. Hartwig, W., Klafs, M., Kirschfink, M., Hackert, T., Schneider, L., Gebhard, M.M., Büchler, M.W., Werner, J., 2006. Interaction of complement and leukocytes in severe acute pancreatitis: potential for therapeutic intervention. Am. J. Physiol. Gastrointest. Liver Physiol., 291(5):G844–G850. [doi:10.1152/ajpgi.00016.2006]PubMedCrossRefGoogle Scholar
  14. Hayashi, T., Ishida, Y., Kimura, A., Iwakura, Y., Mukaida, N., Kondo, T., 2007. IFN-gamma protects cerulein-induced acute pancreatitis by repressing NF-kappa B activation. J. Immunol., 178(11):7385–7394.PubMedGoogle Scholar
  15. Iwagaki, H., Hizuta, A., Uomoto, M., Takeuchi, Y., Kohoka, H., Okamoto, T., Tanaka, N., 1997. Clinical value of cytokine antagonists in infectious complications. Res. Commun. Mol. Pathol. Pharmacol., 96(1):25–34.PubMedGoogle Scholar
  16. Krivoruchko, I.A., Boĭko, V.V., Pesotskiĭ, O.N., Shevchenko, R.S., Klimova, E.M., Drozdova, L.A., 2003. The role of immune disorders information of local and systemic complications of severe acute pancreatitis. Klin. Khir., (2):20–24 (in Russian).Google Scholar
  17. Kylänpää-Bäck, M.L., Takala, A., Kemppainen, E., Puolakkainen, P., Kautiainen, H., Jansson, S.E., Haapiainen, R., Repo, H., 2001. Cellular markers of systemic inflammation and immune suppression in patients with organ failure due to severe acute pancreatitis. Scand. J. Gastroenterol., 36(10):1100–1107. [doi:10.1080/003655201750422738]PubMedCrossRefGoogle Scholar
  18. Kylanpaa, M.L., Mentula, P., Kemppainen, E., Puolakkainen, P., Aittomaki, S., Silvennoinen, O., Haapiainen, R., Repo, H., 2005. Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro. Pancreas, 31(1):23–27. [doi:10.1097/01.mpa.0000164449.23524.94]PubMedCrossRefGoogle Scholar
  19. Ma, M., Geng, Z.Q., He, X.Y., 2002. Improving the prognosis of severe acute pancreatitis by using dexamethasone inhibiting inflammatory mediators. Journal of the Fourth Military Medical University, 23(10):932–934 (in Chinese).Google Scholar
  20. Ma, T., Kang, C., Shao, H., Qi, Q., Hu, W., 2006. Protective effects of ulinastatin on proliferation and cytokine release of splenocytes from rats with severe acute pancreatitis. Eur. Surg. Res., 38(5):445–450. [doi:10.1159/000095087]PubMedCrossRefGoogle Scholar
  21. Malleo, G., Mazzon, E., Siriwardena, A.K., Cuzzocrea, S., 2007. Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence. Shock, 28(2):130–140. [doi:10.1097/shk.0b013e3180487ba1]PubMedCrossRefGoogle Scholar
  22. Matsumura, N., Takeyama, Y., Ueda, T., Yasuda, T., Shinzeki, M., Sawa, H., Nakajima, T., Kuroda, Y., 2007. Decreased expression of toll-like receptor 2 and 4 on macrophages in experimental severe acute pancreatitis. Kobe. J. Med. Sci., 53(5):219–227.PubMedGoogle Scholar
  23. Ohmoto, K., Yamamoto, S., 2005. Serum interleukin-6 and interleukin-10 in patients with acute pancreatitis: clinical implications. Hepatogastroenterology, 52(64):990–994.PubMedGoogle Scholar
  24. Paulino, E.C., de Souza, L.J., Molan, N.A., Machado, M.C., Jancar, S., 2007. Neutrophils from acute pancreatitis patients cause more severe in vitro endothelial damage compared with neutrophils from healthy donors and are differently regulated by endothelins. Pancreas, 35(1): 37–41. [doi:10.1097/MPA.0b013e31805c177b]PubMedCrossRefGoogle Scholar
  25. Pietruczuk, M., Dabrowska, M.I., Wereszczynska-Siemiatkowska, U., Dabrowski, A., 2006. Alteration of peripheral blood lymphocyte subsets in acute pancreatitis. World J. Gastroenterol., 12(33):5344–5351.PubMedGoogle Scholar
  26. Pooran, N., Indaram, A., Singh, P., Bank, S., 2003. Cytokines (IL-6, IL-8, TNF): early and reliable predictors of severe acute pancreatitis. J. Clin. Gastroenterol., 37(3):263–266. [doi:10.1097/00004836-200309000-00013]PubMedCrossRefGoogle Scholar
  27. Rau, B.M., Krüger, C.M., Hasel, C., Oliveira, V., Rubie, C., Beger, H.G., Schilling, M.K., 2006. Effects of immunosuppressive and immunostimulative treatment on pancreatic injury and mortality in severe acute experimental pancreatitis. Pancreas, 33(2):174–183. [doi:10.1097/01.mpa.0000226895.16817.a1]PubMedCrossRefGoogle Scholar
  28. Romagnani, S., 2000. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol., 85(1):9–18.PubMedCrossRefGoogle Scholar
  29. Roxvall, L., Bengtson, A., Sennerby, L., Heideman, M., 1991. Activation of the complement cascade by trypsin. Biol. Chem. Hoppe. Seyler., 372(4):273–278.PubMedGoogle Scholar
  30. Schütte, K., Malfertheiner, P., 2008. Markers for predicting severity and progression of acute pancreatitis. Best Pract. Res. Clin. Gastroenterol., 22(1):75–90. [doi:10.1016/j.bpg.2007.10.013]PubMedCrossRefGoogle Scholar
  31. Sjogren, M.H., 2004. Thymalfasin: an immune system enhancer for the treatment of liver disease. J. Gastroenterol. Hepatol., 19(s6):S69–S72. [doi:10.1111/j.1440-1746.2004.03635.x]CrossRefGoogle Scholar
  32. Skipworth, J.R., Pereira, S.P., 2008. Acute pancreatitis. Curr. Opin. Crit. Care, 14(2):172–178. [doi:10.1097/MCC.0b013e3282f6a3f9]PubMedCrossRefGoogle Scholar
  33. Ueda, T., Takeyama, Y., Yasuda, T., Shinzeki, M., Sawa, H., Nakajima, T., Ajiki, T., Fujino, Y., Suzuki, Y., Kuroda, Y., 2006. Immunosuppression in patients with severe acute pancreatitis. J. Gastroenterol., 41(8):779–784. [doi:10.1007/s00535-006-1852-8]PubMedCrossRefGoogle Scholar
  34. Yao, W., Zhu, Q., Yuan, Y., Qiao, M., Zhang, Y., Zhai, Z., 2007. Thymosin alpha 1 improves severe acute pancreatitis in rats via regulation of peripheral T cell number and cytokine serum level. J. Gastroenterol. Hepatol., 22(11):1866–1871. [doi:10.1111/j.1440-1746.2006.04699.x]PubMedCrossRefGoogle Scholar
  35. Yasuda, T., Takeyama, Y., Ueda, T., Takase, K., Nishikawa, J., Kuroda, Y., 2002. Splenic atrophy in experimental severe acute pancreatitis. Pancreas, 24(4):365–372. [doi:10.1097/00006676-200205000-00007]PubMedCrossRefGoogle Scholar

Copyright information

© Zhejiang University and Springer-Verlag GmbH 2009

Authors and Affiliations

  • Xi-ping Zhang
    • 1
  • Han-qing Chen
    • 2
  • Fang Liu
    • 3
  • Jie Zhang
    • 2
  1. 1.Department of General SurgeryHangzhou First People’s HospitalHangzhouChina
  2. 2.The First College of Clinical MedicineZhejiang University of Traditional Chinese MedicineHangzhouChina
  3. 3.Department of Acupuncture and MoxibustionHangzhou Hospital of Red Cross SocietyHangzhouChina

Personalised recommendations